Similar to rhabdoid and ovarian tumors with SWI/SNF mutations [10–15], complete loss of KDM6A protein sensitizes bladder cancer cell lines and patient-derived xenografts to EZH2 inhibition [22]. This evidence concerns the gene EZH2 and urinary bladder cancer.